Establishment of a WHO Reference Reagent for anti-Mullerian hormone
- PMID: 32799874
- PMCID: PMC7429692
- DOI: 10.1186/s12958-020-00641-9
Establishment of a WHO Reference Reagent for anti-Mullerian hormone
Abstract
Background: There is a need for a reference material to support the development and ensure the quality of immunoassays for human AMH. A batch of ampoules, coded 16/190, containing lyophilised recombinant AMH was evaluated in a WHO Collaborative Study. The aims of the study were to determine the AMH content in terms of the calibration of each immunoassay method, to predict long-term stability and to assess the suitability of the preparation to calibrate AMH immunoassays.
Methods: Study participants were asked to report the AMH content of specific dilutions of coded ampoules of 16/190 and a comparator preparation containing approximately half the AMH content. In each assay, participants also reported the AMH content of 22 patient samples to assess commutability. A robust all-laboratory geometric mean of the content estimates was determined using the laboratory geometric mean estimates. Commutability was assessed using a difference in bias approach. Stability was predicted by the measurement of thermally accelerated degradation samples.
Results: Seven laboratories performed twenty-one immunoassay method-platform combinations, sixteen of which provided data which met the validity criteria, giving a consensus geometric mean estimate of AMH content of 511 ng/ampoule (95% CI, 426-612, n = 16, GCV 42%) and a robust geometric mean of 489 ng/ampoule. By contrast, the GCV% for the all-laboratory geometric mean of the relative content estimates for the comparator sample to 16/190 was 12%. Commutability was assessed using 20 of the 22 representative patient samples. Of the valid assays, 16/190 was within the limits of acceptable commutability for 6 methods, partially commutable for a further 3 methods and non-commutable when measured by 7 methods. The preparation was predicted to be highly stable when stored at - 20 °C.
Conclusion: The majority of methods met the validity criteria. Content estimates showed a high between-method variability, yet assays exhibited a similar proportionality of response as demonstrated using the comparator sample. 16/190 was commutable in some but not all methods. On the basis of these results, it was agreed by the WHO Expert Committee on Biological Standardization to establish 16/190 as a WHO Reference Reagent for AMH with a content defined by consensus immunoassay of 489 ng/ampoule.
Keywords: Anti-Mullerian hormone; Assay; Immunoassay; International standard; Reference material; WHO.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
References
-
- WHO Expert Committee on standardization; sixty-fifth report . World health Organization. 2015. p. 48. - PubMed
-
- Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW, Sherman S, Sluss PM, de Villiers TJ, STRAW + 10 Collaborative Group Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of stagin reproductive aging. J Clin Endocrinol Metab. 2012;97:1159–1168. doi: 10.1210/jc.2011-3362. - DOI - PMC - PubMed
-
- Nelson SM, Iliodromiti S, Fleming R, Anderson R, McConnachie A. Messow CM reference range for the antimüllerian hormone generation II assay: a population study of 10,984 women, with comparison to the established diagnostics systems laboratory nomogram. Fertil Steril. 2014;101:523–529. doi: 10.1016/j.fertnstert.2013.10.021. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous